Lawrence Park
Medical Officer / Psychiatrist at the National Institute of Mental Health (NIMH), NIH
Data updated
Research Footprint
Lawrence Park appears in 5 tracked papers (2017–2020), most studied alongside Ketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Neuroimaging & Brain Measures.
Most-cited paper: Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine (467 citations).
Frequent co-authors: Carlos Zarate, Evan Ballard and Mark John Niciu.
Background & Research
Lawrence T. Park is a psychiatrist and clinical researcher at the National Institute of Mental Health’s Experimental Therapeutics and Pathophysiology Branch. His publications focus on ketamine’s antidepressant and antisuicidal effects, including sleep, dissociation, and neurophysiological predictors of response. He has also coauthored broader reviews on ketamine and serotonergic psychedelics in rapid-acting antidepressant research.
Key Impact
He is a clinician-scientist whose work on ketamine, suicidality, and rapid-acting antidepressant mechanisms has helped shape psychiatric research on psychedelic-adjacent therapeutics.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Lawrence Park is associated with.